• Publications
  • Influence
Peripheral arterial disease detection, awareness, and treatment in primary care.
CONTEXT Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may beExpand
  • 1,499
  • 95
  • PDF
Fibromuscular dysplasia.
  • 373
  • 38
The United States Registry for Fibromuscular Dysplasia: Results in the First 447 Patients
Background— Fibromuscular dysplasia (FMD), a noninflammatory disease of medium-size arteries, may lead to stenosis, occlusion, dissection, and/or aneurysm. There has been little progress inExpand
  • 340
  • 35
  • PDF
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American
Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) A Collaborative Report from the American Association for Vascular Surgery/Society for VascularExpand
  • 2,980
  • 31
  • PDF
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical
Jonathan L. Halperin, MD, FACC, FAHA, Chair Glenn N. Levine, MD, FACC, FAHA, Chair-Elect Sana M. Al-Khatib, MD, MHS, FACC, FAHA Kim K. Birtcher, PharmD, MS, AACC Biykem Bozkurt, MD, PhD, FACC,Expand
  • 660
  • 20
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.
Fibromuscular dysplasia (FMD) is nonatherosclerotic, noninflammatory vascular disease that may result in arterial stenosis, occlusion, aneurysm, or dissection.1–3 The cause of FMD and its prevalenceExpand
  • 255
  • 20
  • PDF
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart
2011 Writing Group Members Thom W. Rooke, MD, FACC, Chair† Alan T. Hirsch, MD, FACC, Vice Chair* Sanjay Misra, MD, FAHA, FSIR, Vice Chair*‡ Anton N. Sidawy, MD, MPH, FACS, Vice Chair§ Joshua A.Expand
  • 198
  • 19
  • PDF
Thromboangiitis obliterans (Buerger's disease).
  • J. Olin, A. Shih
  • Medicine
  • Current opinion in rheumatology
  • 21 September 2000
PURPOSE OF REVIEW Thromboangiitis obliterans is a nonatherosclerotic segmental inflammatory disease that affects the small and medium-sized arteries and veins in the upper and lower extremities. ThisExpand
  • 292
  • 18
Contemporary Management of Postcatheterization Pseudoaneurysms
A pseudoaneurysm (PSA) is a contained rupture; there is a disruption in all 3 layers of the arterial wall (Figure 1). PSAs may occur under 4 circumstances: (1) after catheterization (Figure 2); (2)Expand
  • 171
  • 16
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the
ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From theExpand
  • 927
  • 15